Home NDC 0430-0539 norethindrone acetate and ethinyl estradiol and ferrous fumarate
Product NDC 0430-0539
11-digit product format 004300539
Labeler code 0430
Product ID 0430-0539_185f3a87-1c64-4025-877d-4f4aad6f774f
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name norethindrone acetate and ethinyl estradiol, and ferrous fumarate
Dosage form KIT
Labeler Warner Chilcott (US), LLC
Application NDA204426
Marketing category NDA
Marketing start 2016-05-01
Marketing end 0000-00-00
Active strength 0
NDC exclude flag E
Listing certified through 2018-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 36 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N204426-001 TAYTULLA ETHINYL ESTRADIOL; NORETHINDRONE ACETATE 0.02MG;1MG CAPSULE / ORAL AB RLD, RS 2013-04-19
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N204426-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 42 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N204426-001 TAYTULLA 0.02MG;1MG CAPSULE / ORAL AB RLD, RS 2013-04-19 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N204426-001 TAYTULLA 0.02MG;1MG CAPSULE / ORAL AB RLD, RS 2013-04-19 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204426-001 TAYTULLA 0.02MG;1MG CAPSULE / ORAL AB RLD, RS 2013-04-19 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N204426-001 TAYTULLA 0.02MG;1MG CAPSULE / ORAL AB RLD, RS 2013-04-19 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N204426-001 TAYTULLA 0.02MG;1MG CAPSULE / ORAL AB RLD, RS 2013-04-19 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N204426-001 TAYTULLA 0.02MG;1MG CAPSULE / ORAL AB RLD, RS 2013-04-19 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N204426-001 TAYTULLA 0.02MG;1MG CAPSULE / ORAL AB RLD, RS 2013-04-19 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N204426-001 TAYTULLA 0.02MG;1MG CAPSULE / ORAL AB RLD, RS 2013-04-19 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N204426-001 TAYTULLA 0.02MG;1MG CAPSULE / ORAL AB RLD, RS 2013-04-19 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N204426-001 TAYTULLA 0.02MG;1MG CAPSULE / ORAL AB RLD, RS 2013-04-19 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N204426-001 TAYTULLA 0.02MG;1MG CAPSULE / ORAL AB RLD, RS 2013-04-19 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N204426-001 TAYTULLA 0.02MG;1MG CAPSULE / ORAL AB RLD, RS 2013-04-19 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N204426-001 TAYTULLA 0.02MG;1MG CAPSULE / ORAL AB RLD, RS 2013-04-19 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N204426-001 TAYTULLA 0.02MG;1MG CAPSULE / ORAL AB RLD, RS 2013-04-19 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N204426-001 TAYTULLA 0.02MG;1MG CAPSULE / ORAL AB RLD, RS 2013-04-19 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N204426-001 TAYTULLA 0.02MG;1MG CAPSULE / ORAL AB RLD, RS 2013-04-19 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N204426-001 TAYTULLA 0.02MG;1MG CAPSULE / ORAL AB RLD, RS 2013-04-19 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N204426-001 TAYTULLA 0.02MG;1MG CAPSULE / ORAL AB RLD, RS 2013-04-19 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N204426-001 TAYTULLA 0.02MG;1MG CAPSULE / ORAL RLD, RS 2013-04-19 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N204426-001 TAYTULLA 0.02MG;1MG CAPSULE / ORAL AB RLD, RS 2013-04-19 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N204426-001 TAYTULLA 0.02MG;1MG CAPSULE / ORAL AB RLD, RS 2013-04-19 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N204426-001 TAYTULLA 0.02MG;1MG CAPSULE / ORAL AB RLD, RS 2013-04-19 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N204426-001 TAYTULLA 0.02MG;1MG CAPSULE / ORAL AB RLD, RS 2013-04-19 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N204426-001 TAYTULLA 0.02MG;1MG CAPSULE / ORAL AB RLD, RS 2013-04-19 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N204426-001 TAYTULLA 0.02MG;1MG CAPSULE / ORAL RLD, RS 2013-04-19 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N204426-001 TAYTULLA 0.02MG;1MG CAPSULE / ORAL RLD, RS 2013-04-19 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N204426-001 TAYTULLA 0.02MG;1MG CAPSULE / ORAL RLD, RS 2013-04-19 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N204426-001 TAYTULLA 0.02MG;1MG CAPSULE / ORAL RLD, RS 2013-04-19 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N204426-001 TAYTULLA 0.02MG;1MG CAPSULE / ORAL AB RLD, RS 2013-04-19 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N204426-001 TAYTULLA 0.02MG;1MG CAPSULE / ORAL AB RLD, RS 2013-04-19 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N204426-001 TAYTULLA 0.02MG;1MG CAPSULE / ORAL AB RLD, RS 2013-04-19 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N204426-001 TAYTULLA 0.02MG;1MG CAPSULE / ORAL AB RLD, RS 2013-04-19 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N204426-001 TAYTULLA 0.02MG;1MG CAPSULE / ORAL AB RLD, RS 2013-04-19 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N204426-001 TAYTULLA 0.02MG;1MG CAPSULE / ORAL AB RLD, RS 2013-04-19 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N204426-001 TAYTULLA 0.02MG;1MG CAPSULE / ORAL AB RLD, RS 2013-04-19 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N204426-001 TAYTULLA 0.02MG;1MG CAPSULE / ORAL AB RLD, RS 2013-04-19 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N204426-001 TAYTULLA 0.02MG;1MG CAPSULE / ORAL AB RLD, RS 2013-04-19 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N204426-001 TAYTULLA 0.02MG;1MG CAPSULE / ORAL AB RLD, RS 2013-04-19 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N204426-001 TAYTULLA 0.02MG;1MG CAPSULE / ORAL AB RLD, RS 2013-04-19 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N204426-001 TAYTULLA 0.02MG;1MG CAPSULE / ORAL AB RLD, RS 2013-04-19 e64feba35796…
Observed Orange Book normalized TE history# Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2019-12-13 00:20 UTC 2019-12 N204426-001 6652880 2020-03-29 Drug product 74a2ff9319b5…2020-12-22 03:56 UTC 2020-12 N204426-001 6652880 2020-03-29 Drug product 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N204426-001 6652880 2020-03-29 Drug product c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N204426-001 6652880 2020-03-29 Drug product 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N204426-001 6652880 2020-03-29 Drug product b00525d2431f…2019-07-19 19:46 UTC 2019-07 N204426-001 6652880 2020-03-29 Drug product ea99ee380514…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Taytulla NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, AND FERROUS FUMARATE Allergan, Inc. 2fa8e8dc-f7b0-429a-b554-0e3c4291c92c 2024-10-25 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 204426 application number: NDA204426